Akebia Therapeutics
AKBA

股本结构

单位：万股
公告日期 2025-11-10 2025-11-10 2025-08-07 2025-08-07 2025-05-08 2025-05-08
证券总股本 26536.60 26522.60 26514.50 26304.18 26263.58 26164.46
普通股本 26536.60 26522.60 26514.50 26304.18 26263.58 26164.46
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-11-04 2025-09-30 2025-08-04 2025-06-30 2025-05-05 2025-03-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2025-11-10 26536.60 未披露 定期报告 2025-11-04
2025-11-10 26522.60 未披露
更多>>
From June 30, 2025 to September 30, 2025 Warrants exercised, cashless Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2025-09-30
2025-08-07 26514.50 未披露 定期报告 2025-08-04
2025-08-07 26304.18 未披露
更多>>
From March 31, 2025 to June 30, 2025 Issuance of common stock, net of issuance costs Exercise of options Restricted stock unit vesting
2025-06-30
2025-05-08 26263.58 未披露 定期报告 2025-05-05
2025-04-29 26178.48 未披露 定期报告 2025-04-11
2025-05-08 26164.46 未披露
更多>>
From December 31, 2024 to March 31, 2025 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2025-03-31
2025-03-20 26123.11 未披露
更多>>
Common stock offered 25,000,000 shares of our common stock by company.
2025-03-21
2025-03-13 23623.11 未披露 定期报告 2025-03-10
2025-03-13 22484.90 未披露
更多>>
From December 31, 2023 to December 31, 2024 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting Exercise of options
2024-12-31
2024-11-07 21818.12 未披露 定期报告 2024-11-04
2024-11-07 21154.21 未披露
更多>>
From June 30, 2024 to September 30, 2024 Exercise of options Restricted stock unit vesting Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan
2024-09-30
2024-08-08 21028.82 未披露 定期报告 2024-08-05
2024-08-08 20992.91 未披露
更多>>
From March 31, 2024 to June 30, 2024 Exercise of options Restricted stock unit vesting
2024-06-30
2024-05-09 20959.64 未披露 定期报告 2024-05-07
2024-04-25 20959.53 未披露 定期报告 2024-04-09
2024-05-09 20945.41 未披露
更多>>
From December 31, 2023 to March 31, 2024 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2024-03-31
2024-03-14 20937.23 未披露 定期报告 2024-03-13
2024-03-14 19458.25 未披露
更多>>
From December 31, 2022 to December 31, 2023 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting Exercise of options
2023-12-31
2023-11-08 18838.94 未披露 定期报告 2023-11-06
2023-11-08 18831.38 未披露
更多>>
From June 30, 2023 to September 30, 2023 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
2023-09-30
2023-08-28 18831.38 未披露 定期报告 2023-08-25
2023-08-28 18812.89 未披露
更多>>
From March 31, 2023 to June 30, 2023 Restricted stock unit vesting
2023-06-30
2023-04-28 18592.81 未披露 定期报告 2023-04-18
2023-05-08 18583.59 未披露
更多>>
From December 31, 2022 to March 31, 2023 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
2023-03-31
2023-03-01 18424.80 未披露 定期报告 2023-02-16
2023-03-01 18424.59 未披露 定期报告 2023-01-31
2023-03-10 18413.57 未披露
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting Exercise of options
2022-12-31
2022-11-03 18396.21 未披露 定期报告 2022-10-31
2022-11-03 18395.16 未披露
更多>>
From June 30, 2022 to September 30, 2022 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
2022-09-30
2022-08-04 18384.87 未披露 定期报告 2022-07-31
2022-08-04 18370.47 未披露
更多>>
From March 31, 2022 to June 30, 2022 Exercise of options Restricted stock unit vesting
2022-06-30
2022-04-28 18353.31 未披露 定期报告 2022-04-11
2022-05-09 18338.60 未披露
更多>>
From December 31, 2021 to March 31, 2022 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan:employee stock purchase plan
2022-03-31
2022-03-01 18123.11 未披露 定期报告 2022-02-23
2022-03-01 17700.10 未披露
更多>>
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
2021-12-31
2021-11-04 17496.04 未披露 定期报告 2021-10-31
2021-11-04 17455.20 未披露
更多>>
From June 30, 2021 to September 30, 2021 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
2021-09-30
2021-08-05 17453.75 未披露 定期报告 2021-07-30
2021-08-05 16965.14 未披露
更多>>
From March 31, 2021 to June 30, 2021 Issuance of common stock, net of issuance costs Restricted stock unit vesting
2021-06-30
2021-05-10 16011.52 未披露 定期报告 2021-04-30
2021-04-22 15990.77 未披露 定期报告 2021-04-12
2021-05-10 15852.01 未披露
更多>>
From December 31, 2020 To March 31, 2021 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
2021-03-31
2021-02-25 15350.24 未披露 定期报告 2021-02-19
2021-02-25 14807.41 未披露
更多>>
From December 31,2019 to December 31,2020 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2020-12-31
2020-11-05 14453.89 未披露 定期报告 2020-10-30
2020-11-05 14332.87 未披露
更多>>
From June 30, 2020 to September 30, 2020 Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2020-09-30
2020-08-10 14331.74 未披露 定期报告 2020-07-31
2020-08-10 14312.94 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock, net of issuance costs Exercise of options Restricted stock unit vesting
2020-06-30
2020-05-14 14125.14 未披露
更多>>
1.Common stock offered by Akebia 11,000,000 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 130,251,440 shares outstanding as of March 31, 2020
2020-05-14
2020-05-05 13026.59 未披露 定期报告 2020-04-30
2020-04-23 13026.58 未披露 定期报告 2020-04-09
2020-05-05 13025.14 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2020-03-31
2020-03-12 12985.83 未披露 定期报告 2020-03-01
2020-03-12 12167.46 未披露
更多>>
from December 31, 2018 to December 31, 2019 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Retired shares Restricted stock unit vesting
2019-12-31
2019-11-12 11894.30 未披露 定期报告 2019-10-31
2019-11-12 11886.37 未披露
更多>>
from June 30, 2019 to September 30, 2019 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
2019-09-30
2019-08-08 11886.37 未披露 定期报告 2019-07-31
2019-08-08 11878.73 未披露
更多>>
from March 31, 2019 to June 30,2019 Issuance of common stock, net of issuance costs Exercise of options Retired shares Restricted stock unit vesting
2019-06-30
2019-05-09 11786.26 未披露 定期报告 2019-04-30
2019-04-26 11774.39 未披露 定期报告 2019-04-12
2019-05-09 11712.23 未披露
更多>>
from December 31, 2018 to March 31, 2019 Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2019-03-31
2019-03-26 11712.23 未披露 定期报告 2019-03-15
2019-03-26 11688.75 未披露
更多>>
from December 31, 2017 to December 31, 2018 Issuance of Baupost Additional Shares Issuance of common stock excluding Keryx Merger, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
2018-12-31
2018-10-29 5705.91 未披露 定期报告 2018-10-22
2018-11-08 5704.66 未披露 定期报告 2018-09-30
2018-10-01 5704.66 未披露 定期报告 2018-09-19
2018-08-08 5704.51 未披露 定期报告 2018-07-31
2018-08-08 5691.39 未披露 定期报告 2018-06-30
2018-05-09 5688.32 未披露 定期报告 2018-04-30
2018-04-30 5688.07 未披露 定期报告 2018-04-20
2018-05-09 5685.75 未披露 定期报告 2018-03-31
2018-03-12 4834.62 未披露 定期报告 2018-03-01
2018-03-12 4761.26 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Forfeitures of restricted common stock Exercise of options Restricted stock unit vesting
2017-12-31
2017-11-08 4726.92 未披露 定期报告 2017-10-31
2017-11-08 4723.80 未披露 定期报告 2017-09-30
2017-08-08 4715.14 未披露 定期报告 2017-07-31
2017-08-08 4249.10 未披露 定期报告 2017-06-30
2017-05-09 3886.32 未披露 定期报告 2017-04-30
2017-05-01 3882.96 未披露 定期报告 2017-04-13
2017-05-09 3882.96 未披露 定期报告 2017-03-31
2017-03-06 3882.96 未披露 定期报告 2017-03-01
2017-03-06 3861.57 未披露
更多>>
from December 31, 2015 to December 31, 2016 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Forfeitures of restricted common stock Exercise of options
2016-12-31
2016-11-09 3832.45 未披露 定期报告 2016-10-31
2016-11-09 3825.32 未披露 定期报告 2016-09-30
2016-08-08 3801.16 未披露 定期报告 2016-07-31
2016-08-08 3800.89 未披露 定期报告 2016-06-30
2016-05-05 3797.67 未披露 定期报告 2016-04-30
2016-05-05 3794.60 未披露 定期报告 2016-03-31
2016-03-14 3794.29 未披露 定期报告 2016-03-01
2016-03-14 3066.22 未披露
更多>>
from December 31, 2014 to December 31, 2015 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Forfeitures of restricted common stock Exercise of options
2015-12-31
2015-11-09 3063.17 未披露 定期报告 2015-11-05
2015-11-09 3021.81 未披露 定期报告 2015-09-30
2015-08-11 2888.25 未披露 定期报告 2015-06-30
2015-05-11 2883.73 未披露 定期报告 2015-05-01
2015-05-11 2047.36 未披露 定期报告 2015-03-31
2015-03-04 2037.06 未披露
更多>>
from December 31, 2013 to December 31, 2014 Conversion of preferred stock Accretion of preferred stock to redemption value Issuance of common stock Issuance of restricted common stock Forfeitures of restricted common stock Exercise of options Treasury shares purchased, not retired (2,553) Treasury shares purchased, retired (5,910) A 1.75-for-1 forward stock split of our common stock that we effected on March 6, 2014
2014-12-31
2014-11-10 2034.08 未披露 定期报告 2014-10-31
2014-11-10 2030.02 未披露 定期报告 2014-09-30
2014-08-11 2026.30 未披露 定期报告 2014-06-30
2014-05-12 2026.23 未披露 定期报告 2014-04-30
2014-05-12 2026.27 未披露 定期报告 2014-03-31
2014-03-21 1926.80 未披露
更多>>
A 1.75-for-1 forward stock split of our common stock that we effected on March 6, 2014 The conversion of all of our outstanding shares of preferred stock into 12,002,329 shares of common stock, which is calculated based upon accrued dividends through December 31, 2013 and excludes 112,853 shares of common stock issuable upon conversion of our Series C preferred stock at the closing of this offering with respect to dividends accrued between December 31, 2013 and the consummation of the offering
2014-03-20
2014-03-07 138.33 532.49
更多>>
Give effect to a 1.75-for-1 forward stock split that we effected on March 6, 2014
2014-03-07
2014-02-14 79.05 532.49
更多>>
from December 31, 2012 to December 31, 2013 Sale of Series C preferred stock, net of issuance costs of $1,151,923 Conversion of 2012 Series X preferred stock into Series C preferred stock Issuance of restricted common stock Issuance of common stock Exercise of stock options Forfeitures of restricted common stock
2013-12-31
From June 30, 2025 to September 30, 2025 Warrants exercised, cashless Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
From March 31, 2025 to June 30, 2025 Issuance of common stock, net of issuance costs Exercise of options Restricted stock unit vesting
From December 31, 2024 to March 31, 2025 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
Common stock offered 25,000,000 shares of our common stock by company.
From December 31, 2023 to December 31, 2024 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting Exercise of options
From June 30, 2024 to September 30, 2024 Exercise of options Restricted stock unit vesting Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan
From March 31, 2024 to June 30, 2024 Exercise of options Restricted stock unit vesting
From December 31, 2023 to March 31, 2024 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
From December 31, 2022 to December 31, 2023 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting Exercise of options
From June 30, 2023 to September 30, 2023 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
From March 31, 2023 to June 30, 2023 Restricted stock unit vesting
From December 31, 2022 to March 31, 2023 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
From December 31, 2021 to December 31, 2022 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting Exercise of options
From June 30, 2022 to September 30, 2022 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
From March 31, 2022 to June 30, 2022 Exercise of options Restricted stock unit vesting
From December 31, 2021 to March 31, 2022 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan:employee stock purchase plan
From December 31, 2020 to December 31, 2021 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
From June 30, 2021 to September 30, 2021 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
From March 31, 2021 to June 30, 2021 Issuance of common stock, net of issuance costs Restricted stock unit vesting
From December 31, 2020 To March 31, 2021 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
From December 31,2019 to December 31,2020 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
From June 30, 2020 to September 30, 2020 Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
From March 31, 2020 to June 30, 2020 Issuance of common stock, net of issuance costs Exercise of options Restricted stock unit vesting
1.Common stock offered by Akebia 11,000,000 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 130,251,440 shares outstanding as of March 31, 2020
From December 31, 2019 to March 31, 2020 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
from December 31, 2018 to December 31, 2019 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Retired shares Restricted stock unit vesting
from June 30, 2019 to September 30, 2019 Proceeds from sale of stock under employee stock purchase plan Restricted stock unit vesting
from March 31, 2019 to June 30,2019 Issuance of common stock, net of issuance costs Exercise of options Retired shares Restricted stock unit vesting
from December 31, 2018 to March 31, 2019 Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
from December 31, 2017 to December 31, 2018 Issuance of Baupost Additional Shares Issuance of common stock excluding Keryx Merger, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Exercise of options Restricted stock unit vesting
from December 31, 2016 to December 31, 2017 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Forfeitures of restricted common stock Exercise of options Restricted stock unit vesting
from December 31, 2015 to December 31, 2016 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Forfeitures of restricted common stock Exercise of options
from December 31, 2014 to December 31, 2015 Issuance of common stock, net of issuance costs Proceeds from sale of stock under employee stock purchase plan Forfeitures of restricted common stock Exercise of options
from December 31, 2013 to December 31, 2014 Conversion of preferred stock Accretion of preferred stock to redemption value Issuance of common stock Issuance of restricted common stock Forfeitures of restricted common stock Exercise of options Treasury shares purchased, not retired (2,553) Treasury shares purchased, retired (5,910) A 1.75-for-1 forward stock split of our common stock that we effected on March 6, 2014
A 1.75-for-1 forward stock split of our common stock that we effected on March 6, 2014 The conversion of all of our outstanding shares of preferred stock into 12,002,329 shares of common stock, which is calculated based upon accrued dividends through December 31, 2013 and excludes 112,853 shares of common stock issuable upon conversion of our Series C preferred stock at the closing of this offering with respect to dividends accrued between December 31, 2013 and the consummation of the offering
Give effect to a 1.75-for-1 forward stock split that we effected on March 6, 2014
from December 31, 2012 to December 31, 2013 Sale of Series C preferred stock, net of issuance costs of $1,151,923 Conversion of 2012 Series X preferred stock into Series C preferred stock Issuance of restricted common stock Issuance of common stock Exercise of stock options Forfeitures of restricted common stock
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。